Recent Updates
Recently added Catalysts
KPTI Positive Sentiment Score: 70/100

Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences

Wednesday, March 6, 2024 1 min read
Key Takeaway: Karyopharm Therapeutics Inc. will have its senior management team participate in two prominent healthcare conferences. They are scheduled to present at the Barclays 26th Annual Global Healthcare Conference on March 13, 2024, and participate in the Leerink Partners Global Biopharma Conference on March 12, 2024. These events offer the company an opportunity to showcase its novel cancer therapies to a wider audience.

Market Sentiment Analysis

POSITIVE FACTORS

  • Karyopharm Therapeutics is participating in significant industry conferences.
  • The company will present innovative cancer therapies to a global audience.
  • Management engagement indicates a proactive approach to investor relations.

Full Press Release Details

NEWTON, Mass., March 6, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate in the Leerink Partners Global Biopharma Conference on Tuesday, March 12, 2024 and present at the Barclays 26th Annual Global Healthcare Conference in a fireside chat on Wednesday, March 13, 2024 at 9:00 a.m. ET in Miami Beach, FL.
A live webcast of the fireside chat at the Barclays conference can be accessed under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations, and will be available for replay following the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.
SOURCE Karyopharm Therapeutics Inc.

21 %

more press release views with

Frequently Asked Questions

When will Karyopharm participate in the Leerink Partners conference?

Karyopharm will participate in the Leerink Partners Global Biopharma Conference on March 12, 2024.

What will Karyopharm present at the Barclays conference?

Karyopharm will present in a fireside chat at the Barclays Global Healthcare Conference on March 13, 2024.

How can I access the Barclays conference webcast?

The webcast can be accessed under 'Events & Presentations' on Karyopharm's investor website.

What are the trademarks of Karyopharm Therapeutics?

XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc.

Tags: KPTI Viatris Investor Conferences Healthcare Karyopharm cancer therapies healthcare conferences biopharma
Last updated: Mar 6, 2024